Peripheral arterial disease is only the tip of the atherosclerotic "iceberg".
The peripheral vascular system makes up the largest single "organ system" and holds many biological secrets that, when unlocked, can open doors for new treatments for all vascular beds, including those of the coronary and cerebral arteries. The coronary and noncoronary circulations are inseparable and interdependent. Cardiologists as well as primary care physicians should have a global view in the management of patients with PAD. The treatment of atherosclerosis in any of the arterial beds is a multifactorial problem. PAD is underrecognized. Antiplatelet and lipid-lowering therapy is underutilized in patients with PAD. Clopidogrel, an antiplatelet drug, has proven to prevent adverse cardiovascular events in patients with PAD. Therapeutic angiogenesis has been reported to improve severe claudication.
Futterman
Laurie G
LG
Department of Medicine, University of Miami School of Medicine, FL 33101, USA.
Lemberg
Louis
L
D001158:Arteries / Q000473:pathology*; D001161:Arteriosclerosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D003131:Combined Modality Therapy; D016638:Critical Illness; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D012307:Risk Factors